Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
This grant supports research on improving alcohol treatment services for individuals with alcohol use disorder, targeting access, appeal, costs, dissemination, and health disparities.
Funder: National Institutes of Health
Due Dates: May 17, 2025 (Letter of Intent) | June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | September 16, 2025 (Letter of Intent) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | January 17, 2026 (Letter of Intent) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | May 17, 2026 (Letter of Intent) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 direct costs in any single year.
Summary: Supports R34 clinical trials to develop, pilot, or plan research on improving treatment and recovery for alcohol use disorder (AUD), including medications, behavioral therapies, health services, and reducing disparities.
Key Information: Clinical trial required; only human studies are allowed; foreign organizations are eligible.
Description
This opportunity, offered by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at NIH, supports R34 planning grants for clinical trials focused on alcohol treatment, pharmacotherapy, and recovery research. The goal is to close the treatment gap for individuals with alcohol use disorder (AUD) by supporting pilot or planning studies that will inform future, larger-scale clinical trials.
Research areas of interest include:
- Development and evaluation of new or repurposed medications for AUD
- Precision medicine and identification of predictors of treatment response
- Behavioral therapies and mechanisms of behavioral change (MOBC)
- Recovery processes, including risk/resilience factors and long-term outcomes
- Translational research applying neuroscience and genetics to treatment
- Innovative methods and technologies (e.g., digital health, telemedicine)
- Health services research, including access, cost, insurance, and implementation
- Reducing health disparities and improving care for underserved populations
Applications must propose a clinical trial in humans (no animal studies). Projects may include pilot studies, feasibility studies, or planning activities for future clinical trials.
